Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-09-01. Active
80 1600 1127 1847 1455 3000 0001
31 1600 1127 1847 1455 3000 0010
26 1600 1127 1847 1455 3000 0003
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $7.3M$7,297,552 |
Buildings and premises | $38.9M$38,886,118 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 4, 2021 | Commercial Companies Code notice |
Public aid
33 public aid cases recorded, with a total value of $4,840,965.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 13, 2026 | Investment aid for the promotion of energy from renewable sources | $26,452$26,452 | Zarządca Rozliczeń S.A. | |
| Jun 15, 2026 | Investment aid for the promotion of energy from renewable sources | $24,039$24,039 | Zarządca Rozliczeń S.A. | |
| May 12, 2026 | Investment aid for the promotion of energy from renewable sources | $21,665$21,665 | Zarządca Rozliczeń S.A. |
Tenders
1440 tenders recorded as contractor: 211 national ($12,095,279) and 1229 EU ($4,074,149,901).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 14, 2026 | Zakup i sukcesywna dostawa leków do programów lekowych | –– | Szpital Wolski Im. Dr Anny Gostyńskiej sp. z o.o. | |
| Oct 14, 2026 | Zakup i sukcesywna dostawa produktów leczniczych stosowanych w programach lekowych i RDTL(5] | –– | Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji | |
| Oct 13, 2026 | Dostawa produktów leczniczych i wyrobów medycznych oraz leków stosowanych w programach lekowych | –– | Wojewódzki Szpital Podkarpacki Im. Jana Pawła II w Krośnie |
Public sector contracts
LEK is the contractor in 237 public sector contracts, worth PLN 35.23m in total. They were signed with 105 public buyers. The largest number (7) were signed with Uniwersytecki Szpital Kliniczny w Białymstoku.
| Public buyer | Value | |
|---|---|---|
| Samodzielny Publiczny Kliniczny Szpital Okulistyczny w Warszawie | PLN 63,082 | |
| Wielkopolskie Centrum Pulmonologii I Torakochirurgii Im. Eugenii I Janusza Zeylandów | PLN 1,860 | |
| Szpital Kliniczny Ministerstwa Spraw Wewnętrznych I Administracji z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie | PLN 176,400 | |
| Szpital Specjalistyczny Im. Jędrzeja Śniadeckiego w Nowym Sączu | PLN 60,615 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej w Mońkach | PLN 2.16 |
Public procurement disputes (KIO)
LEK has been a party to 23 cases before the National Appeal Chamber (since 2008). It filed 19 appeals (9 upheld, 7 dismissed, 3 discontinued). In 4 cases it joined the proceedings as a participant.
Trademarks
LEK holds 25 active trademarks registered with the Polish Patent Office. 74 marks have expired or were not registered. The first mark was filed in 1990.
| Mark | Protected until | |
|---|---|---|
| ALTACET ORTHO(word) | Sep 17, 2035 | |
| BETO 25 ZK(word) | Feb 12, 2034 | |
| BETO 200 ZK(word) | Feb 12, 2034 | |
| BETO 150 ZK(word) | Feb 12, 2034 | |
| BETO 100 ZK(word) | Feb 12, 2034 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Electricity generation | Active | ||
| Waste generation | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently or a commercial proxy independently is authorised to submit declarations of will and sign on behalf of the company.
Supervisory board
Ownership
| Owner |
|---|
Sandoz Ag |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $1,364,908,839.78 | polpharma.pl | ||
| Adamed PharmaS.A. | $541,927,181.76 | adamed.com.pl | ||
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Fresenius Kabi Polskasp. z o.o. | $247,097,438.47 | fresenius-kabi.com | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $160,174,284.28 | anpharm.pl | ||
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl |
Change history
| Date | Event | |
|---|---|---|
| 2010-11-23 | Share capital change (5,725,700.00 PLN → 11,409,350.00 PLN) | |
| 2008-04-01 | Share capital change (2,603,700.00 PLN → 5,725,700.00 PLN) | |
| 2003-09-01 | Address change (Sarnia 3/5, 90-972, Łódź → Podlipie 16, 95-010, Stryków) | |
| 2003-09-01 | Name change (Zakład Farmaceutyczny "argon" → Lek) | |
| 2001-11-16 | Entered in the register |
FAQ
Last updated: 2026-10-05